IMC Chicago’s Insulet PODD Stock Holding History

IMC Chicago’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,959	Closed	-$7.18M	–	4352
2025 Q3	$7.09M	Buy	+22,959	New	+$7.19M	﹤0.01%	1346

Other funds holding PODD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

IMC Chicago's PODD Position: Q4 2025 in Review

IMC Chicago sold out of Insulet (PODD) in Q4 2025, closing a stake of 22,959 shares — an estimated $7.18M sold.

IMC Chicago first reported a position in PODD in Q3 2025 and held it in 1 quarter. The position peaked at $7.09M in Q3 2025. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

IMC Chicago reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
IMC Chicago sold 22,959 Insulet shares in Q4 2025, an estimated $7.18M.
IMC Chicago first reported a position in Insulet in Q3 2025 and held it in 1 quarter.
IMC Chicago's Insulet position peaked at $7.09M in Q3 2025.
832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.